Tata Chemicals Limited has informed the Exchange about Investor Presentation
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tata Chemicals reported Q4FY26 consolidated revenue of ₹3,438 Cr and EBITDA of ₹274 Cr, both declining year-on-year due to lower soda ash realisations across geographies. The quarter saw a net loss of ₹279 Cr after accounting for a ₹1,837 Cr goodwill impairment charge in the US business due to challenging soda ash market conditions. For FY26, revenue stood at ₹14,584 Cr with EBITDA of ₹1,805 Cr, while PAT before exceptional items was ₹241 Cr. Despite headwinds, non-soda ash revenue grew 14% to ₹6,946 Cr, driven by new capacities. Debt increased to ₹5,961 Cr (from ₹4,884 Cr) impacted by rupee depreciation and lower cash generation. The company commissioned multiple new plants including Mithapur's 1 MTPA soda ash facility, a salt plant in UK, Pearl grade Silica in Cuddalore, and completed the Novabay pharma bi-carb acquisition in Singapore. The board recommended dividend of ₹11 per share.
The ₹1,837 Cr impairment and increased debt raise concerns about near-term profitability and balance sheet strength, though the low debt-to-equity ratio of 0.36 and dividend recommendation provide some comfort. The shift toward non-soda ash revenue and multiple new capacity additions position the company for diversification, but investors should monitor soda ash pricing recovery.